Ali Al-nashif, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 7240 Sheridan Rd Ste 101, White Hall, AR 71602 Phone: 870-247-6105 Fax: 870-247-6106 |
News Archive
Scientists are working to end the need for human heart transplants by 2028. A team of researchers in the UK, Cambridge, and the Netherlands are developing a robot heart that can pump blood through the circulatory network but is soft and pliable. The first working model should be ready for implantation into animals within the next 3 years, and into humans within the next 8 years.
MAP Pharmaceuticals, Inc. today announced that it has completed a planned interim safety review of the open-label, long-term safety extension of the company's Phase 3 FREEDOM 301 clinical trial with its LEVADEX(TM) orally inhaled migraine therapy.
Middle age may not be too late for women to substantially reduce their stroke risk by not smoking, exercising, maintaining a healthy weight and making healthy food choices, according to new research published today in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.
An Australian biotech company whose largest shareholder is a U.S. congressman has the greenlight to begin human trials in the U.S. for a drug to treat advanced multiple sclerosis.
AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that it has entered into a ten-year contract to supply radiation therapy services at Hospital Santa Paula (HSP) in São Paulo, Brazil. AMS will place an advanced technology linear accelerator with IMRT capabilities at HSP, and is expected to begin treating patients in early 2012 in conjunction with the expected completion of a new comprehensive cancer center to be built by the hospital.
› Verified 8 days ago